Eurofins Secures Environment Testing Market Leadership in Finland with the Acquisition of the Laboratory Bus. of Ramboll Group
April 03 2017 - 6:01AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), the global leader in food and
environment testing, announces that it has acquired the analytical
laboratory business of Ramboll Group (“Ramboll”) in Finland
comprising 5 laboratories specialized in environment testing.
Ramboll has built a clear market leadership in Finland
throughout its 100-year history, offering the widest range of
analytical services for environment testing. Its laboratories serve
industrial companies, public municipalities as well as consulting
companies. The company employs 109 staff across 4 laboratories in
the southern region around Helsinki, as well as at a satellite
laboratory in Tallinn, Estonia.
As the largest environment testing service provider in Finland,
Ramboll has developed strong inroads with the largest customers in
both the private and public sectors. The acquisition provides
Eurofins with a market-leading position in environment testing, and
a strong platform on which to accelerate the deployment of the
Group’s capabilities in Finland, as well as a platform for entry
into the Estonian market. In return, the acquired laboratories will
have access to the entire portfolio of Eurofins’ testing methods,
logistics, and other Group resources, which should allow it to
further expand market share. The transaction should therefore
benefit customers who will continue to enjoy the high quality
services previously offered by Ramboll’s laboratories, complemented
with an improved and wider range of analytical as well as IT
services.
Comment from Lone A. Clowes, Regional Director at Ramboll
Environment & Health: “While Ramboll Analytics has a strong
foothold on the Finnish market, it is a very specialised service
requiring dedicated development and investment strategies. We
believe that the analytics business will have the best development
opportunities in a company that is fully focused on the laboratory
sector”.
Comment from Dr. Gilles Martin, Eurofins CEO: “The
acquisition of Ramboll laboratories in Finland reflects Ramboll
Group’s confidence that Eurofins has the capabilities to
successfully develop these over the long term. It also reflects our
commitment to further strengthen Eurofins’ position as the leading
private, independent analytical testing service provider in
Finland”.
For more information, please visit
www.eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter
sometimes “Eurofins” or “the Group”) believes it is the world
leader in food, environment and pharmaceutical products testing and
that it is also one of the global independent market leaders in
certain testing and laboratory services for agroscience, genomics,
discovery pharmacology and for supporting clinical studies. In
addition, Eurofins is one of the key emerging players in specialty
clinical diagnostic testing in Europe and the USA. With over 27,000
staff in 310 laboratories across 39 countries, Eurofins offers a
portfolio of over 130,000 analytical methods for evaluating the
safety, identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170403005650/en/
Investor RelationsEurofins ScientificPhone: +32 2 766
1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024